Works matching IS 13570560 AND DT 2023 AND VI 40 AND IP 3
Results: 22
MORC2 and MAX contributes to the expression of glycolytic enzymes, breast cancer cell proliferation and migration.
- Published in:
- Medical Oncology, 2023, v. 40, n. 3, p. 1, doi. 10.1007/s12032-023-01974-2
- By:
- Publication type:
- Article
Identification of potential tumor antigens and immune subtypes for lung adenocarcinoma.
- Published in:
- Medical Oncology, 2023, v. 40, n. 3, p. 1, doi. 10.1007/s12032-023-01973-3
- By:
- Publication type:
- Article
The in vitro treatment of mesenchymal stem cells for colorectal cancer cells.
- Published in:
- Medical Oncology, 2023, v. 40, n. 3, p. 1, doi. 10.1007/s12032-023-01972-4
- By:
- Publication type:
- Article
Neolamarckia cadamba (Roxb.) Bosser (Rubiaceae) extracts: promising prospects for anticancer and antibacterial potential through in vitro and in silico studies.
- Published in:
- Medical Oncology, 2023, v. 40, n. 3, p. 1, doi. 10.1007/s12032-023-01971-5
- By:
- Publication type:
- Article
Design of a potential Sema4A-based multi-epitope vaccine to combat triple-negative breast cancer: an immunoinformatic approach.
- Published in:
- Medical Oncology, 2023, v. 40, n. 3, p. 1, doi. 10.1007/s12032-023-01970-6
- By:
- Publication type:
- Article
Erythrose inhibits the progression to invasiveness and reverts drug resistance of cancer stem cells of glioblastoma.
- Published in:
- Medical Oncology, 2023, v. 40, n. 3, p. 1, doi. 10.1007/s12032-023-01969-z
- By:
- Publication type:
- Article
The past, present, and future of immunotherapy for colorectal cancer.
- Published in:
- Medical Oncology, 2023, v. 40, n. 3, p. 1, doi. 10.1007/s12032-023-01967-1
- By:
- Publication type:
- Article
Upregulation of TUBG1 expression promotes hepatocellular carcinoma development.
- Published in:
- Medical Oncology, 2023, v. 40, n. 3, p. 1, doi. 10.1007/s12032-023-01966-2
- By:
- Publication type:
- Article
Function of TRPC1 in modulating hepatocellular carcinoma progression.
- Published in:
- Medical Oncology, 2023, v. 40, n. 3, p. 1, doi. 10.1007/s12032-023-01964-4
- By:
- Publication type:
- Article
Propionate-producing Veillonella parvula regulates the malignant properties of tumor cells of OSCC.
- Published in:
- Medical Oncology, 2023, v. 40, n. 3, p. 1, doi. 10.1007/s12032-023-01962-6
- By:
- Publication type:
- Article
Wnt3a is a promising target in colorectal cancer.
- Published in:
- Medical Oncology, 2023, v. 40, n. 3, p. 1, doi. 10.1007/s12032-023-01958-2
- By:
- Publication type:
- Article
Epidemiological trends and risk factors of gynecological cancers: an update.
- Published in:
- Medical Oncology, 2023, v. 40, n. 3, p. 1, doi. 10.1007/s12032-023-01957-3
- By:
- Publication type:
- Article
Clinical application of liquid biopsy in endometrial carcinoma.
- Published in:
- Medical Oncology, 2023, v. 40, n. 3, p. 1, doi. 10.1007/s12032-023-01956-4
- By:
- Publication type:
- Article
Chemotherapy: how to reduce its adverse effects while maintaining the potency?
- Published in:
- Medical Oncology, 2023, v. 40, n. 3, p. 1, doi. 10.1007/s12032-023-01954-6
- By:
- Publication type:
- Article
CAFs secrete CXCL12 to accelerate the progression and cisplatin resistance of colorectal cancer through promoting M2 polarization of macrophages.
- Published in:
- Medical Oncology, 2023, v. 40, n. 3, p. 1, doi. 10.1007/s12032-023-01953-7
- By:
- Publication type:
- Article
Niosomes nanoparticles as a novel approach in drug delivery enhances anticancer properties of chrysin in human ovarian carcinoma cells (SKOV3): an in vitro study.
- Published in:
- Medical Oncology, 2023, v. 40, n. 3, p. 1, doi. 10.1007/s12032-023-01952-8
- By:
- Publication type:
- Article
Relationship between glioblastoma multiforme (GBM) and Alzheimer's disease (AD): is there any reporting bias?
- Published in:
- 2023
- By:
- Publication type:
- Letter
Photodynamic therapy in oral cancer: a review of clinical studies.
- Published in:
- Medical Oncology, 2023, v. 40, n. 3, p. 1, doi. 10.1007/s12032-023-01949-3
- By:
- Publication type:
- Article
B7-H6 enhances F-actin rearrangement by targeting c-MYC activation to promote medulloblastoma migration and invasion.
- Published in:
- Medical Oncology, 2023, v. 40, n. 3, p. 1, doi. 10.1007/s12032-023-01947-5
- By:
- Publication type:
- Article
NLRP3 inflammasome activation By 17β-estradiol is a potential therapeutic target in hepatocellular carcinoma treatment.
- Published in:
- Medical Oncology, 2023, v. 40, n. 3, p. 1, doi. 10.1007/s12032-022-01945-z
- By:
- Publication type:
- Article
Immune checkpoint inhibitor using in cases with gestational trophoblastic diseases.
- Published in:
- Medical Oncology, 2023, v. 40, n. 3, p. 1, doi. 10.1007/s12032-022-01941-3
- By:
- Publication type:
- Article
RUNX3 improves CAR-T cell phenotype and reduces cytokine release while maintaining CAR-T function.
- Published in:
- Medical Oncology, 2023, v. 40, n. 3, p. 1, doi. 10.1007/s12032-022-01913-7
- By:
- Publication type:
- Article